Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The type II secretion system of Legionella pneumophila promotes pathogenesis. Among the Legionella type II-dependent exoenzymes is a p-nitrophenol phosphorylcholine (p-NPPC) hydrolase whose activity is only partially explained by the PlcA
phospholipase C
. In a screen to identify other factors that promote secreted hydrolase activity, we isolated a mip mutant. L. pneumophila Mip is a surface-exposed, FK506-binding protein that is needed for optimal infection and has
peptidylproline cis-trans-isomerase
(
PPIase
) activity. Since the molecular target of Mip was undefined, we investigated a possible relationship between Mip and the secreted p-NPPC hydrolase activity. In the mip mutant there was a 40 to 70% reduction in secreted activity that was successfully complemented by providing mip on a plasmid. A similar phenotype was observed when we examined four other independently derived mip mutants, and in all cases the defect was complemented by reintroduction of mip. Thus, mip promotes the presence of a p-NPPC hydrolase activity in culture supernatants. We also found that the C terminus of Mip is required for this effect. When supernatants were examined by anion-exchange chromatography, the p-NPPC hydrolase activity associated with Mip proved to be type II dependent but distinct from PlcA. This conclusion was supported by the phenotype of a newly constructed mip plcA double mutant. Thus, Mip promotes the elaboration of a new type II exoprotein. These data provide both the first evidence for a target for Mip and the first indication that a surface
PPIase
is involved in the secretion or activation of proteins beyond the outer membrane.
...
PMID:Legionella pneumophila Mip, a surface-exposed peptidylproline cis-trans-isomerase, promotes the presence of phospholipase C-like activity in culture supernatants. 1692 7
Peptidyl-prolyl
cis/trans
isomerases (PPIases) are enzymes that catalyze the
cis
-to-
trans
isomerization around proline bonds, allowing proteins to fold into their correct confirmation. Previously, we identified two
PPIase
enzymes in
Staphylococcus aureus
(PpiB and PrsA) that are involved in the regulation of virulence determinants and have shown that PpiB contributes to
S. aureus
virulence in a murine abscess model of infection. Here, we further examine the role of these PPIases in
S. aureus
virulence and, in particular, their regulation of hemolytic toxins. Using murine abscess and systemic models of infection, we show that a
ppiB
mutant in a USA300 background is attenuated for virulence but that a
prsA
mutant is not. Deletion of the
ppiB
gene leads to decreased bacterial survival in macrophages and nasal epithelial cells, while there is no significant difference when
prsA
is deleted. Analysis of culture supernatants reveals that a
ppiB
mutant strain has reduced levels of the phenol-soluble modulins and that both
ppiB
and
prsA
mutants have reduced
alpha-toxin
activity. Finally, we perform immunoprecipitation to identify cellular targets of PpiB and PrsA. Results suggest a novel role for PpiB in
S. aureus
protein secretion. Collectively, our results demonstrate that PpiB and PrsA influence
S. aureus
toxins via distinct mechanisms, and that PpiB but not PrsA contributes to disease.
...
PMID:Novel Regulation of Alpha-Toxin and the Phenol-Soluble Modulins by Peptidyl-Prolyl
cis/trans
Isomerase Enzymes in
Staphylococcus aureus
. 3120 55